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A patient with metastatic melanoma developed symmetric miliary infiltrates of the lungs while receiving
injections of MER into tumor containing lymph nodes of the groin. Open lung biopsy identified the
pulmonary lesions as caseating epithelioid granulomas. After cessation of MER therapy, the pulmonary
lesions regressed spontaneously. The possible etiology of this so-far-unreported complication of MER
therapy was briefly discussed.
INTRODUCTION
The complications of Bacillus Calmette-Guerin (BCG) immunotherapy have been
recently reviewed in detail [1]. The most serious include fatal anaphylactic reactions,
disseminated BCG infection and hepatic dysfunction. Although the majority ofthose
complications have been noted with intratumoral BCG, complications ofthis nature
have also been reported using scarification techniques [2]. A recent report implicated
oral BCG as a cause of granulomatous pneumonitis [3].
The use of the methanol extraction residue of BCG (MER) as a non-specific
immunopotentiator is attractive because itavoids administration oflive organisms to
immunosuppressed patients. The extract is also more readily quantified, considered
stable, and of low toxicity [4].
A previously unreported complication of intratumoral MER is presented.
Case Report
A 51 year old white female with surgically resected Stage II melanoma (positive
nodes) of the left lower extremity was seen at the University of Connecticut Health
Center for consideration of adjuvant immumotherapy.
Immunologic evaluation at this time showed her to be reactive to two offour recall
antigens in vivo (mumps and streptokinase/streptodornase). Lymphocyte prolifera-
tive response to the non-specific T cell mitogens, phytohemagglutinin and concana-
valin A, was normal. Stimulation indices in vitro to specific antigens (candida,
mumps, streptokinase/streptodornase) were all greater than 12. However, response
to purified protein derivative of tuberculin both in vivo and in vitro was negative.
Immunoglobulin levels were normal. Clinical evaluation revealed no evidence of
distant metastases.
The patient was given a total of 0.5 mg of MER BCG (Phipps Strain) intrader-
mally into 5 sites according to the protocol of Dr. Mitchell.' Four weeks after
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admission into the protocol, the patient developed multiple amelanotic nodules
around the lymphadenectomy incision site in the groin and a subcutaneous mass
appeared just below the incision.
The patient was then given intralesional MER. A test dose of50 ugm (25 ug each in
each of two skin nodules) was injected and the patient responded vigorously within
24 hours with local erythema and induration. There was an associated systemic
reaction with chills and temperature reaching 39.5C.
Four days later, 20 additional nodules were injected, using a total dose of40 ug. A
single dose of hydrocortisone, 100 mg intramuscular, was administered one hour
after MER injection and no fever or chills developed. One week later, the remaining
skin nodules were injected with another 40 ug dose of MER.
Shortly following the last injection, the patient complained of fatigue and a dry
cough. Chest radiograph at this time, in striking contrast to a previous normal study
three weeks earlier, revealed a fine nodular miliary pattern involving both lungs
symmetrically suggesting an interstitial pattern (Figs. 1 and 2). The differential
diagnosis included granulomatous disease, pneumoconiosis, hypersensitivity, sarcoid
or highly vascular metastatic neoplasms [5,6]. Arterial blood gases and respiratory
screening function tests were within normal limits.
A transient minimal elevation ofthe alkaline phosphatase was the only laboratory
abnormality noted. Liver scan at this time was normal.
Repeat immune testing at this time showed reactivity to PPD both in vivo and in
vitro. Peripheral blood T cells (by E rosette) and B cells (by EAC rosette) were
normal in number.
In order to clarify the nature ofthe pulmonary changes, an open lung biopsy was
performed.
Light microscopic examination of the lung biopsy revealed numerous histiocytic
granulomas measuring up to 1 mm in diameter. Admixed with the histiocytes, there
were scattered lymphocytes and occasional multi-nucleated giant cells (Fig. 3a, b).
The central portion of the larger granulomas had undergone caseation necrosis. No
acid-fast bacilli or particles were identified in slides stained according to the Ziehl-
Neelsen method.
Within a month after cessation of MER therapy, the chest infiltrate had cleared
completely.
DISCUSSION
Miliary granuloma of the liver and lung have been reported as complications of
BCG therapy by various routes of administration [1,2,3]. Only rarely are organisms
recovered from these lesions [2]. MER is purportedly a cell free extract ofBCG, and
it is not surprising that no mycobacteria were found in the lung of this patient.
The appearance of caseating granulomas in the lungs was interpreted as a sign of
local hypersensitivity reaction, although we have not identified the causative antigen
nor fully elucidated the exact pathogenesis. The formation ofgranulomas in the lungs
was temporarily related to MER treatment, and the discontinuation of MER therapy
led to spontaneous regression of pulmonary lesions. One could thus postulate that
the formation of granulomas occurred due to the presence of an incitive antigen in
the MER or that MER treatment only potentiated and made possible a localized
granulomatous response to an inhalation antigen. The latterexplanation seems more
plausible. An analogy could be made between our observation and an experiment
reported by Petersen et al. [7]. In those experiments, animals were exposed to an
inhalation antigen, known to produce pigeon breeders' disease, and concomitantly
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FIG. 1. Postero-anterior roentgenogram, showing bilateral miliary infiltrates.
injected with killed BCG. Animals developed a granulomatous cell-mediated hyper-
sensitivity reaction localized exclusively to the lungs.
The main purpose of this report was to indicate that MER may produce pulmon-
ary granulomas. Unanticipated as it was in our patient, this complication may be
confused with dissemination ofthe tumor, miliary tuberculosis or some other granu-
lomatous or fulminant infectious disease. In future cases that develop pulmonary
infiltrates while on MER therapy for cancer, tissue diagnosis of the lesion may be
required, but a more conservative approach could be also chosen, since it appears
that the granulomas could spontaneously regress upon cessation of therapy, as
illustrated in the present case.
FIG. 2. Detail of left mid-lung field.
667668 LUNDY ET AL.
FIG. 3. Pulmonary granuloma a. low powerviewofthe lesion. H & E x 120. b. high powerview ofthe granuloma. Note
caseation necrosis and multi-nucleated giant cells. H & E x 210.
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